Charles Sawyers
Hematology & Oncology · New York, NY
CMS Profile ID: 1219074 · NPI: 1063432052
Total Disclosed General Payments
$1,307,357.18
General-payment records
11
CMS Program Year
2025
Most of this (about 97%) was acquisition payments.
Payments by Type
| Payment Type | Amount |
|---|---|
| Acquisitions | $1,266,522.00 |
| Consulting Fee | $40,835.18 |
Top Paying Companies
| Manufacturer / GPO | Amount |
|---|---|
| GENZYME CORPORATION | $1,271,522.00 |
| Blueprint Medicines Corporation | $15,835.18 |
| BeOne Medicines USA, Inc. | $11,666.67 |
| BeiGene, Ltd. | $5,000.00 |
| BeOne Medicines Ltd. | $3,333.33 |
Top contributing companies shown; smaller payers may be omitted.
These totals are computed from the official CMS Open Payments program-year 2025 general-payment
file. To see the full, authoritative record for this provider — including research payments and
line-item detail — look them up by exact NPI 1063432052 on the
official CMS Open Payments portal.
Verify this record with CMS
- Confirm the provider's exact NPI: 1063432052.
- Select program year 2025 and general payments in the CMS portal.
- Check individual payment records and their nature-of-payment categories.